• Company
• Management Team
• Products
• Science
• Medical Advisory Board
• Globestar^®

Science

Imagenetix seeks to be a leader in conducting cutting edge scientific studies on its proprietary, natural-based bioceutical and pharmaceutical products. Where appropriate, those Imagenetix products that are proprietary and substantial enough to participate in multi-million to multi-billion dollar markets will be subjected to professionally designed clinical studies and seek FDA approval as a pharmaceutical.

Imagenetix is a company which focuses on inflammatory related conditions. The Company identifies and develops nutritional or pharmaceutical products that may provide a solution to this challenge. Studies are designed that could produce insight into such important issues as toxicity and effectiveness. Top laboratories, universities, and clinics are utilized. Recognized doctors and pharmaceutical researchers with published backgrounds are selected to oversee the studies. By involving top caliber professionals, the Company is able to quickly gain confidence in determining whether or not to proceed with ongoing studies.

If the Company proceeds with studies, and if the results are positive, the findings by these professionals are likely to receive support throughout the industry. By utilizing this process, the Company has automatically increased the likelihood of getting its scientific findings published

While conducting tests, Management focuses on two main ways in which its scientifically tested products might ultimately be marketed:

First: The majority of the Company’s research will lead to products that will quickly find their way to market as oral or topical natural-based products and where the Company can make structure/function claims for the oral products or cosmetic claims for the topical products. Effective scientific results will allow distributors to market and consumers to buy products with confidence. With solid science, many distribution channels can be utilized.